4//SEC Filing
HAQUE PROMOD 4
Accession 0001209191-19-048051
CIK 0001636422other
Filed
Sep 2, 8:00 PM ET
Accepted
Sep 3, 9:00 PM ET
Size
7.7 KB
Accession
0001209191-19-048051
Insider Transaction Report
Form 4
HAQUE PROMOD
Director10% Owner
Transactions
- Award
Common Stock
2019-09-01+3,557→ 3,557 total
Holdings
- 2,952,091(indirect: See Footnote)
Common Stock
- 2,952,090(indirect: See Footnote)
Common Stock
Footnotes (3)
- [F1]Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, the RSUs will fully vest on the date of the next Annual Meeting of the Issuer's Stockholders.
- [F2]The securities shown on Line 2 of Table I represent securities held of record by Norwest Venture Partners XI, LP ("NVP XI"). By virtue of his position as a Co-Chief Executive Officer of NVP Associates, LLC ("NVP Associates"), the managing member of the general partner of NVP XI, Promod Haque may be deemed to share voting and dispositive power with respect to such securities. Mr. Haque disclaims beneficial ownership of all such securities, except to the extent of any pecuniary interest therein.
- [F3]The securities shown on Line 3 of Table I represent securities held of record by Norwest Venture Partners XII, LP ("NVP XII"). By virtue of his position as a Co-Chief Executive Officer of NVP Associates, LLC ("NVP Associates"), the managing member of the general partner of NVP XII, Promod Haque may be deemed to share voting and dispositive power with respect to such securities. Mr. Haque disclaims beneficial ownership of all such securities, except to the extent of any pecuniary interest therein.
Documents
Issuer
Health Catalyst, Inc.
CIK 0001636422
Entity typeother
IncorporatedCA
Related Parties
1- filerCIK 0001089744
Filing Metadata
- Form type
- 4
- Filed
- Sep 2, 8:00 PM ET
- Accepted
- Sep 3, 9:00 PM ET
- Size
- 7.7 KB